European cancer mortality predictions for the year 2019 with focus on breast cancer
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND To overcome the lag with which cancer statistics become available, we predicted numbers of deaths and rates from all cancers and selected cancer sites for 2019 in the European Union (EU). MATERIALS AND METHODS We retrieved cancer death certifications and population data from the World Health Organization and Eurostat databases for 1970-2014. We obtained estimates for 2019 with a linear regression on number of deaths over the most recent trend period identified by a logarithmic Poisson joinpoint regression model. We calculated the number of avoided deaths over the period 1989-2019. RESULTS We estimated about 1 410 000 cancer deaths in the EU for 2019, corresponding to age-standardized rates of 130.9/100 000 men (-5.9% since 2014) and 82.9 women (-3.6%). Lung cancer trends in women are predicted to increase 4.4% between 2014 and 2019, reaching a rate of 14.8. The projected rate for breast cancer was 13.4. Favourable trends for major neoplasms are predicted to continue, except for pancreatic cancer. Trends in breast cancer mortality were favourable in all six countries considered, except Poland. The falls were largest in women 50-69 (-16.4%), i.e. the age group covered by screening, but also seen at age 20-49 (-13.8%), while more modest at age 70-79 (-6.1%). As compared to the peak rate in 1988, over 5 million cancer deaths have been avoided in the EU over the 1989-2019 period. Of these, 440 000 were breast cancer deaths. CONCLUSION Between 2014 and 2019, cancer mortality will continue to fall in both sexes. Breast cancer rates will fall steadily, with about 35% decline in rates over the last three decades. This is likely due to reduced hormone replacement therapy use, improvements in screening, early diagnosis and treatment. Due to population ageing, however, the number of breast cancer deaths is not declining.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318 · cited 1×
“To identify the most recent trend segment, we fitted a logarithmic Poisson count data joinpoint regression model to each 5-year agespecific number of certified deaths [9], setting a maximum of six segments.”
MethodFerlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Gavin, A., Visser, O., & Bray, F. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.07.005 · Cited by 2,478 · cited 1×
“In any case, the actual data confirmed our previous mortality predictions for 2014 [1] and predicted figures from this work are consistent with other modelling projections [37].”
Result(2015) · The Lancet · doi:10.1016/s0140-6736(15)61074-1 · Cited by 1,520
International Variation in Female Breast Cancer Incidence and Mortality Rates
DeSantis, C. E., Bray, F., Ferlay, J., Lortet-Tieulent, J., Anderson, B. O., & Jemal, A. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0535 · Cited by 804 · cited 1×
“Breast cancer incidence has been rising in some Northern and Eastern European countries, has remained stable in several others, and some declines were only registered in southern European countries [18].”
BackgroundColorectal cancer screening: An updated review of the available options
Issa, I. A., & Noureddine, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i28.5086 · Cited by 572 · cited 1×
“The lower prevalence in Helicobacter pylori infection over subsequent decades and the decline in tobacco use in men, along with better dietary habits caused marked declines in stomach cancer [32]; advancement in screening and treatments reduced mortality for colorectal cancer [33].”
BackgroundPrevention and early detection of prostate cancer
Cuzick, J., Thorat, M. A., Andriole, G., Brawley, O. W., Brown, P. H., Culig, Z., Eeles, R. A., Ford, L. G., Hamdy, F. C., Holmberg, L., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70211-6 · Cited by 495 · cited 1×
“Prevention and early detection, together with modern medical, surgical and radiological therapies favourably affect prostate cancer mortality, too [36].”
BackgroundCollaborative Group on Epidemiological Studies of Ovarian Cancer (2015) · The Lancet · doi:10.1016/s0140-6736(14)61687-1 · Cited by 472
Cumberbatch, M. G., Rota, M., Catto, J. W. F., & La Vecchia, C. (2016) · European Urology · doi:10.1016/j.eururo.2015.06.042 · Cited by 451 · cited 1×
“Exposure to occupational carcinogens and tobacco influenced trends in bladder cancer [31], explaining the fourfold higher rates and larger decline in men.”
BackgroundSelf-citationEuropean cancer mortality predictions for the year 2014
Malvezzi, M., Bertuccio, P., Levi, F., La Vecchia, C., & Negri, E. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu138 · Cited by 382
Self-citationEpidemiology of Obesity in Adults: Latest Trends
Inoue, Y., Qin, B., Poti, J., Sokol, R., & Gordon-Larsen, P. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0317-8 · Cited by 308 · cited 3×
“Since death certification figures are available with a few years lag, our group has been publishing cancer mortality predictions for the current year for the European Union (EU) since 2011 [1, 2], as has been long done for the United States [3].”
BackgroundTrends and predictions to 2020 in breast cancer mortality in Europe
Carioli, G., Malvezzi, M., Rodriguez, T., Bertuccio, P., Negri, E., & La Vecchia, C. (2017) · The Breast · doi:10.1016/j.breast.2017.06.003 · Cited by 264 · cited 3×
“In the EU, breast cancer is the second cause of cancer death in women, despite favourable mortality trends since the 1990s [13].”
BackgroundSelf-citationOverweight and obesity in 16 European countries
Gallus, S., Lugo, A., Murisic, B., Bosetti, C., Boffetta, P., & La Vecchia, C. (2015) · European Journal of Nutrition · doi:10.1007/s00394-014-0746-4 · Cited by 260 · cited 2×
“Tobacco control is partly counterbalanced by the increase in obesity and diabetes registered in several European countries over the last decade [17], as well as in the United States [28].”
BackgroundSelf-citationBasu, P., Ponti, A., Anttila, A., Ronco, G., Senore, C., Vale, D. B., Segnan, N., Tomatis, M., Soerjomataram, I., Primic Žakelj, M., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31043 · Cited by 251
Hormonal contraception and risk of cancer
Cibula, D., Gompel, A., Mueck, A. O., La Vecchia, C., Hannaford, P. C., Skouby, S. O., Zikan, M., & Dusek, L. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq022 · Cited by 246 · cited 1×
“The persisting and substantial downward trends in ovarian cancer over the last three decades are mainly due to the long-term protective effects of oral contraceptive (OC) use [29].”
BackgroundSelf-citationTabár, L., Dean, P. B., Chen, T. H., Yen, A. M., Chen, S. L., Fann, J. C., Chiu, S. Y., Ku, M. M., Wu, W. Y., Hsu, C., et al. (2019) · Cancer · doi:10.1002/cncr.31840 · Cited by 246 · cited 1×
“A Swedish observational study estimated the impact of modern mammography in reducing breast cancer mortality between 47% and 60% at age 40–69 [22], though quantification is still under discussion [23].”
BackgroundEuropean cancer mortality predictions for the year 2018 with focus on colorectal cancer
Malvezzi, M., Carioli, G., Bertuccio, P., Boffetta, P., Levi, F., La Vecchia, C., & Negri, E. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy033 · Cited by 211 · cited 2×
“Since death certification figures are available with a few years lag, our group has been publishing cancer mortality predictions for the current year for the European Union (EU) since 2011 [1, 2], as has been long done for the United States [3].”
BackgroundSelf-citationImpact of Screening on Breast Cancer Mortality: The UK Program 20 Years On
Massat, N. J., Dibden, A., Parmar, D., Cuzick, J. M., Sasieni, P. D., & Duffy, S. W. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0803 · Cited by 139 · cited 1×
“Thus, the downward mortality trends are due to screening (organized, but also spontaneous), early diagnosis and therapy [13, 19, 20].”
BackgroundPopat, K. U., McQueen, K., & Feeley, T. W. (2013) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2013.10.010 · Cited by 111 · cited 1×
“In contrast, the number of deaths rises moderately, due to the European population ageing and increasing in size [10].”
BackgroundGlobal Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017
Lucas, A. L., Malvezzi, M., Carioli, G., Negri, E., Vecchia, C. L., Boffetta, P., & Bosetti, C. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.05.034 · Cited by 111 · cited 1×
“Pancreatic cancer is the major site not showing favourable trends in recent years; in men the predicted trend reaches a plateau, in women it has still been rising; only in young men some declines were registered [27].”
BackgroundSelf-citationTrends and predictions to 2020 in breast cancer mortality: Americas and Australasia
Carioli, G., Malvezzi, M., Rodríguez, T., Bertuccio, P., Negri, E., & Vecchia, C. L. (2017) · The Breast · doi:10.1016/j.breast.2017.12.004 · Cited by 104 · cited 1×
“Favourable breast cancer trends were also observed in highincome countries in North America and Oceania, but less consistent patterns were observed in Latin America and several other middle-income countries [26].”
BackgroundSelf-citationLung cancer mortality in European women: Trends and predictions
Bosetti, C., Malvezzi, M., Rosso, T., Bertuccio, P., Gallus, S., Chatenoud, L., Levi, F., Negri, E., & Vecchia, C. L. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.08.008 · Cited by 99
Self-citationThe role of Helicobacter pylori infection in the web of gastric cancer causation
Peleteiro, B., Vecchia, C. L., & Lunet, N. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32834a7f66 · Cited by 96 · cited 1×
“The lower prevalence in Helicobacter pylori infection over subsequent decades and the decline in tobacco use in men, along with better dietary habits caused marked declines in stomach cancer [32]; advancement in screening and treatments reduced mortality for colorectal cancer [33].”
BackgroundGallus, S., Lugo, A., Vecchia, C. L., Boffetta, P., Chaloupka, F. J., Colombo, P., Currie, L. M., Fernández, E., Fischbacher, C., Gilmore, A., et al. (2014) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000009 · Cited by 90 · cited 1×
“The more marked favourable trend in men likely reflects the different changes in smoking patterns over generations of the two sexes [11].”
BackgroundSelf-citationCancer mortality predictions for 2017 in Latin America
Carioli, G., Vecchia, C. L., Bertuccio, P., Rodríguez, T., Levi, F., Boffetta, P., Negri, E., & Malvezzi, M. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx301 · Cited by 51 · cited 1×
“In 2017 and 2018, we also published corresponding figures for a selection of other countries with good quality data [4, 5].”
BackgroundSelf-citationPerimenopausal risk factors and future health
The ESHRE Capri Workshop Group (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr020 · Cited by 48
Bailey, C., Richardson, L. C., Allemani, C., Bonaventure, A., Harewood, R., Moore, A. R., Stewart, S. L., Weir, H. K., Coleman, M. P., & CONCORD Working Group (US members) (2018) · Cancer · doi:10.1002/cncr.31674 · Cited by 45 · cited 1×
“Improvements in diagnosis and screening positively impact cervix uteri incidence [34], and better therapeutic procedures caused declines in leukaemia mortality trends [35].”
BackgroundRosato, V., Bosetti, C., Negri, E., Talamini, R., Maso, L. D., Malvezzi, M., Falcini, F., Montella, M., & Vecchia, C. L. (2013) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3283639f7a · Cited by 39 · cited 1×
“Reproductive and hormonal factors, and obesity in postmenopausal women, are the main recognized determinants of breast cancer [14, 15].”
BackgroundSelf-citationA Quick Guide to Cancer Epidemiology
Boffetta, P., Boccia, S., & Vecchia, C. L. (2014) · Springer eBooks · doi:10.1007/978-3-319-05068-3 · Cited by 32 · cited 1×
“Reproductive and hormonal factors, and obesity in postmenopausal women, are the main recognized determinants of breast cancer [14, 15].”
BackgroundSelf-citationThe rise and fall in menopausal hormone therapy and breast cancer incidence
Pelucchi, C., Levi, F., & Vecchia, C. L. (2010) · The Breast · doi:10.1016/j.breast.2010.01.021 · Cited by 30 · cited 1×
“The decline in menopausal hormone use may also partly explain the falls in mortality trends [25].”
BackgroundSelf-citationDimitrova, N., Znaor, A., Agius, D., Eser, S., Šekerija, M., Ryzhov, A., Primic‐Žakelj, M., Coebergh, J. W. W., Agius, D., Coza, D., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.06.011 · Cited by 29 · cited 1×
“These also reflect improvements in breast cancer management [21].”
BackgroundCancer mortality and predictions for 2018 in selected Australasian countries and Russia
Carioli, G., Malvezzi, M., Bertuccio, P., Levi, F., Boffetta, P., Negri, E., & Vecchia, C. L. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy489 · Cited by 18 · cited 1×
“In 2017 and 2018, we also published corresponding figures for a selection of other countries with good quality data [4, 5].”
BackgroundSelf-citation
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
de Wit, R., de Bono, J., Sternberg, C. N., Fizazi, K., Tombal, B., Wülfing, C., Kramer, G., Eymard, J.-C., Bamias, A., Carles, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911206 · Cited by 663
Simon, T. G., Roelstraete, B., Sharma, R., Khalili, H., Hagström, H., & Ludvigsson, J. F. (2021) · Hepatology · doi:10.1002/hep.31845 · Cited by 176
Uncovering Prognosis-Related Genes and Pathways by Multi-Omics Analysis in Lung Cancer
Asada, K., Kobayashi, K., Joutard, S., Tubaki, M., Takahashi, S., Takasawa, K., Komatsu, M., Kaneko, S., Sese, J., & Hamamoto, R. (2020) · Biomolecules · doi:10.3390/biom10040524 · Cited by 67
“Within these cases, the most common cause of cancer death was lung cancer, and 280,000 are expected to die from lung cancer in 2019 [3].”
BackgroundLleras de Frutos, M., Medina, J. C., Vives, J., Casellas‐Grau, A., Marzo, J. L., Borràs, J. M., & Ochoa‐Arnedo, C. (2020) · Psycho-Oncology · doi:10.1002/pon.5457 · Cited by 50
Metadata
- Authors
- Malvezzi, M., Carioli, G., Bertuccio, P., Boffetta, P., Levi, F., La Vecchia, C., & Negri, E.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 30
- Issue
- 5
- Pages
- 781-787
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2590857018
- Cited by
- 237
- References
- 32
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.